IOSP Innospec Inc
Price (delayed)
$106.48
Market cap
$2.66B
P/E Ratio
17.72
Dividend/share
$1.48
EPS
$6.01
Enterprise value
$2.46B
Innospec Inc. is an international specialty chemicals company with approximately 1900 employees in 24 countries. Innospec manufactures and supplies a wide range of specialty chemicals to markets in the Americas,
Highlights
The stock's price to earnings (P/E) is 43% less than its 5-year quarterly average of 31.0 and 16% less than its last 4 quarters average of 21.1
The quick ratio is up by 24% YoY
The debt rose by 10% since the previous quarter and by 4.8% year-on-year
Innospec's revenue has decreased by 6% YoY and by 2.3% QoQ
Key stats
What are the main financial stats of IOSP
Market
Valuations
Earnings
Shares outstanding
24.94M
Market cap
$2.66B
Enterprise value
$2.46B
Price to earnings (P/E)
17.72
Price to book (P/B)
2.23
Price to sales (P/S)
1.4
EV/EBIT
13.15
EV/EBITDA
10.76
EV/Sales
1.3
Revenue
$1.89B
EBIT
$187.4M
EBITDA
$229M
Free cash flow
$148.5M
Per share
Balance sheet
Liquidity
EPS
$6.01
Free cash flow per share
$5.96
Book value per share
$47.83
Revenue per share
$75.95
TBVPS
$50.15
Total assets
$1.7B
Total liabilities
$504.4M
Debt
$48.1M
Equity
$1.19B
Working capital
$544M
Debt to equity
0.04
Current ratio
2.63
Quick ratio
1.62
Net debt/EBITDA
-0.84
Margins
Efficiency
Dividend
EBITDA margin
12.1%
Gross margin
30.4%
Net margin
7.9%
Operating margin
9.5%
Return on assets
8.9%
Return on equity
12.9%
Return on invested capital
26.4%
Return on capital employed
13.7%
Return on sales
9.9%
Dividend yield
1.39%
DPS
$1.48
Payout ratio
24.6%
IOSP stock price
How has the Innospec stock price performed over time
Intraday
0.42%
1 week
-2.76%
1 month
0.07%
1 year
1.73%
YTD
-13.6%
QTD
-13.84%
Financial performance
How have Innospec's revenue and profit performed over time
Revenue
$1.89B
Gross profit
$575.5M
Operating income
$179M
Net income
$149.6M
Gross margin
30.4%
Net margin
7.9%
The net margin rose by 25% year-on-year and by 3.9% since the previous quarter
Innospec's net income has increased by 18% YoY
The operating margin has increased by 12% year-on-year and by 7% since the previous quarter
Innospec's revenue has decreased by 6% YoY and by 2.3% QoQ
Growth
What is Innospec's growth rate over time
Valuation
What is Innospec stock price valuation
P/E
17.72
P/B
2.23
P/S
1.4
EV/EBIT
13.15
EV/EBITDA
10.76
EV/Sales
1.3
The stock's price to earnings (P/E) is 43% less than its 5-year quarterly average of 31.0 and 16% less than its last 4 quarters average of 21.1
The company's EPS rose by 18% YoY
The P/B is 14% less than the last 4 quarters average of 2.6 and 3% less than the 5-year quarterly average of 2.3
The equity is up by 9% YoY
The price to sales (P/S) is 7% lower than the 5-year quarterly average of 1.5 and 7% lower than the last 4 quarters average of 1.5
Innospec's revenue has decreased by 6% YoY and by 2.3% QoQ
Efficiency
How efficient is Innospec business performance
IOSP's ROA is up by 14% year-on-year
The company's return on sales rose by 13% YoY and by 5% QoQ
IOSP's return on invested capital is up by 12% year-on-year and by 2.3% since the previous quarter
Innospec's ROE has increased by 9% YoY
Dividends
What is IOSP's dividend history
DPS
$1.48
Dividend yield
1.39%
Payout ratio
24.6%
Recent dividends
Special dividends are included in TTM DPS and yield
Financial health
How did Innospec financials performed over time
The quick ratio is up by 24% YoY
The current ratio has grown by 12% YoY and by 5% from the previous quarter
The debt is 96% smaller than the equity
The debt rose by 10% since the previous quarter and by 4.8% year-on-year
The equity is up by 9% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.